Novo Nordisk Earnings: Wegovy Pill Beats Forecasts as Novo Raises Outlook
Novo Nordisk earnings: Q3 sales of 79.2 billion kroner beat forecasts as the Wegovy pill took in 5.4 billion, and Novo raised its 2026 outlook. Data inside.
World News, Politics and War, Reported from Boston
Novo Nordisk earnings: Q3 sales of 79.2 billion kroner beat forecasts as the Wegovy pill took in 5.4 billion, and Novo raised its 2026 outlook. Data inside.
CVS Health split: CVS will spin off its 9,000 drugstores as CVS Pharmacy by 2028 as Q3 revenue hits $108.4 billion and it raises 2026 guidance. Data inside.
The Boston Report Briefing: a free weekly email with five important stories, election updates, local data and our latest investigations.